Medical History Form. Part 1. Administrative Information

Size: px
Start display at page:

Download "Medical History Form. Part 1. Administrative Information"

Transcription

1 Medical History Form ID NUMBER: FORM CODE: MHX VERSION:A 02/10/10 Contact Occasion 0 1 SEQ # Administrative Information 0a. Completion Date: / / 0b. Staff ID: Part 1 Instructions: Part 1 of this form is completed by participant-response. Affix the participant ID label above. 1. Prior Angina... No Yes Unknown [ Angina refers to evidence or knowledge of symptoms before this acute event described as chest pain or pressure, jaw pain, arm pain, or other equivalent discomfort suggestive of cardiac ischemia] Comment [KBR1]: Do we want to add Do you have a history of to the beginning of these first 7 questions? 1a. If YES, then choose one of the following: Existed > 2 weeks before admission Existed 2 weeks before admission 2. Previous Myocardial Infarction... No Yes Unknown [Diagnosed by physician and hospitalized for myocardial infarction] 3. Prior Percutaneous Coronary Intervention... No Yes Unknown 3a. If YES, most recent PCI date: / / 4. Prior Coronary Artery Bypass Surgery... No Yes Unknown 4a. If YES, most recent CABG date : / / 5. History of Stroke... No Yes Unknown 5a. If YES, then answer the following: Hemiplegia:... No Yes 6. History of TIA... No Yes Unknown [A focal neurological deficit (usually corresponding to the territory of a single vessel) that resolves spontaneously without evidence of residual symptoms at 24 hours] 7. History of peripheral arterial disease... No Yes Unknown [Peripheral arterial disease can include the following: (1) Claudication (pain in the muscles in the back of the legs), either with exertion or at rest (2) Amputation for arterial vascular insufficiency (3) Vascular reconstruction, bypass surgery, or percutaneous intervention to the extremities (4) Documented aortic aneurysm (5) Positive noninvasive test (e.g., ankle brachial index less than 0.8). Medical History (MHX) Page 1 of 10

2 8. Do you have a history of congestive heart failure?... No Yes Unknown 8a. If YES, then classify heart failure: NYHA Class I No symptoms and no limitation in ordinary physical activity (e.g. shortness of breath when walking, climbing stairs etc). NYHA Class II Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. NYHA Class III Marked limitation in activity due to symptoms, even during less-than-ordinary activity. Comfortable only at rest. NYHA Class IV Severe limitations. Experiences symptoms at rest. Inability to carry out physical activity or symptoms at rest. 9. Do you currently smoke or have you smoked in the past?. No Yes If YES, answer the following: 9a. Current (within 1 month) Recent (stopped 1 month to 1 year prior) Former (stopped > 1 year prior) 9b. Years of smoking: 9c. Cigarettes smoked per day: cigarettes per day (1 = 1 or fewer per day) 10. Do you have a family history of coronary disease?... No Yes Unknown (As documented by direct blood relatives parents, siblings, children who have had any of the following before age 55: 1) angina, or 2) myocardial infarction, or 3) sudden cardiac death without obvious cause) In the three months prior to this visit today: 11. Were you exercising regularly?... No Yes Unknown 12. Were you following a low-cholesterol, low-fat diet?... No Yes Unknown 13. Were you participating in a cardiac rehabilitation program?... No Yes Unknown 14. Many people do not take their medications perfectly. In the three months before this hospitalization, did you ever miss taking your medications?... No Yes Unknown 15. Did any medical professional discuss with you the importance of taking your medications? Were you taking aspirin on a daily basis during the 7 days before you came to the hospital? Were you taking vitamins or supplements?... If yes, please list: Medical History (MHX) Page 2 of 10

3 Part 2 Instructions: Part 2 of this form is completed by chart abstraction. A. RISK FACTORS 18. Height:... inches 19. Weight:... lbs Note: For Questions 20 42, Unknown = No documentation of Positive or Negative History OR Unclear documentation. 20. Hypertension... No Yes Unknown (As documented by 1) diagnosis by a health care provider, or 2) SBP > 140 or DBP > 90 mmhg on at least 2 occasions, or 3) current use of antihypertensive medication) 21. Diabetes... No Yes Unknown (As documented by 1) diagnosis by a health care provider, or 2) current use of antidiabetic medication) 22. Dyslipidemia... No Yes Unknown (As documented by (1) diagnosis by a health care provider, or (2) current use of hypolipidemic medication) 23. History of cigarette smoking... No Yes Unknown If Yes, answer the following: a. Current (within 1 month) Recent (stopped 1 month to 1 year prior) Former (stopped > 1 year prior) b. Years of smoking: c. Cigarettes smoked per day: Cigarettes per day (1 = 1 or fewer per day) 24. Family history of coronary disease... No Yes Unknown (As documented by direct blood relatives parents, siblings, children who have had any of the following before age 55: 1) angina, or 2) myocardial infarction, or 3) sudden cardiac death without obvious cause) B. CARDIOVASCULAR DISEASE HISTORY 25. Angina... No Yes Unknown (As documented by evidence or knowledge of symptoms before the index ACS event described as chest pain or pressure, jaw pain, arm pain, or other equivalent discomfort suggestive of cardiac ischemia) Medical History (MHX) Page 3 of 10

4 26. Myocardial infarction... No Yes Unknown (As documented by 1) physician diagnosis, or 2) hospitalization for MI) 26a. If Yes, most recent date: / / 27. Percutaneous Coronary Intervention (PCI)... No Yes Unknown 27a. If Yes, most recent date: / / 28. Coronary Artery Bypass Surgery (CABG)... No Yes Unknown 28a. If Yes, most recent date: / / 29. Stroke... No Yes Unknown 29a. If Yes, most recent date: / / 30. TIA... No Yes Unknown (As documented by focal neurological deficit, usually corresponding to the territory of a single vessel, that resolves spontaneously without evidence of residual symptoms at 24 hour) 31. Peripheral Arterial Disease... No Yes Unknown (As documented by 1) claudication, either with exertion or at rest, 2) amputation for arterial vascular insufficiency, 3) vascular reconstruction, CABG, or PCI to the extremities, 4) aortic aneurysm, 5) positive noninvasive test (e.g., ankle brachial index < 0.8)) 32. Congestive heart failure... No Yes Unknown a. If Yes, NYHA class:.. I II III IV Medical History (MHX) Page 4 of 10

5 C. OTHER COMORBID ILLNESS HISTORY 33. Chronic lung disease... No Yes Unknown (As documented by 1) asthma, 2) chronic obstructive pulmonary disease, 3) chronic bronchitis, or 4) emphysema) 34. Kidney disease... No Yes Unknown 35. Liver disease... No Yes Unknown 35a. If Yes, severity: Mild (e.g. chronic hepatitis, or cirrhosis without complications such as varices, portal hypertension, encephalopathy, GI bleeding) Moderate/Severe (e.g. cirrhosis with complications such as varices, portal hypertension, encephalopathy, GI bleeding) 36. Rheumatologic disease... No Yes Unknown (As documented by lupus (SLE), polymyagia rheumatica (PMR), polymyositis, mixed connective tissue disease, polymyalgia rheumatica, or rheumatoid arthritis (RA)) 37. Peptic ulcer disease... No Yes Unknown (As documented by treatment for ulcer or history of GI bleed due to ulcer) Note: gastritis without ulcer does not count as peptic ulcer disease 38. AIDS... No Yes Unknown Note: not including those with asymptomatic HIV+ 39. Any cancer treated in the past 5 years. No Yes Unknown (e.g., breast, lung, colon, prostate, brain, etc.) 40. Leukemia (blood cancer)... No Yes Unknown (e.g., AML, CML, ALL, CLL, polycythemia vera) 41. Lymphoma (lymph node cancer)... No Yes Unknown (e.g., Hodgkins, lymphosarcoma, Waldenstrom s macroglobulinemia, myeloma, and other lymphomas) 42. Thyroid disease... No Yes Unknown a. If Yes, type:... Hyperthyroidism Hypothyroidism 43. Other co-morbid illness... No Yes a. b. c. Medical History (MHX) Page 5 of 10

6 D. INDEX ACUTE CORONARY SYNDROME (ACS) EVENT Comment [KBR2]: Need to renumber the rest of this section 27. Hospital Name: 28. Hospital admission date: / / 29. Transferred from another hospital?... No Yes If Yes: a. Hospital Name: b. If Yes, transfer date: / / 30. Date of ACS diagnosis: / / 31. Hospital discharge date: / / 32. Heart rate at initial hospital presentation:... bpm 33. SBP/DBP at initial presentation:... / mmhg 34. Killip class at initial presentation:... I II III IV 35. Cardiac arrest at initial presentation? No Yes 36. Heart rate at discharge:... bpm 37. SBP/DBP at discharge:... / mmhg E. ECG FINDINGS FOR INDEX ACS EVENT 38a. Admitting ECG available? No Yes a. Date of ECG: / / b. Time of ECG: : AM / PM Hour Minute (circle one) 38b. Pre-discharge ECG available? No Yes a. Date of ECG: / / b. Time of ECG: : AM / PM Hour Minute (circle one) Medical History (MHX) Page 6 of 10

7 39. ECG changes?... No Yes (If Yes, retain copy of ECG on which diagnosis is made, and a subsequent ECG after evolution of the changes) a. For the diagnostic ECG, indicate type(s) of ECG changes (check all that apply): ST-segment elevation 0.1 mv elevation in 2 or more contiguous leads Q waves greater 0.04 seconds in width and 0.1 mv in depth in at least 2 contiguous leads ST-segment depression > 0.05 mv in 2 more contiguous leads (includes reciprocal changes) T-wave inversion of at least 0.1 mv b. For the ECG after evolution of the changes, indicate the pattern:... Q wave non-q wave 40. Paced rhythm?... No Yes 41. Atrial fibrillation or flutter?... No Yes 42. Bundle branch block?... No Yes a. Type... RBBB LBBB b. Timing... New Old Unknown F. LABORATORY TESTS DURING HOSPITALIZATION FOR INDEX ACS EVENT 43. Troponin I or T performed?... No Yes a. Instrument:... ctni (cardiac troponin I) ctnt (cardiac troponin T) Other, specify: b. Assay:... Abbott AxSYM ADV Radiometer AQT90 Abbott Architect Response RAMP Abbott i-stat Roche E170 Beckman Access Accu Roche Elecsys 2010 Beckman Access hs-ctni Siemens Centaur Ultra biomerieux Vidas Ultra Siemens Dimension RxL Innotrac Aio! Siemens Immulite 2500 Inverness Biosite Triage Siemens Stratus CS Mitsubishi PATHFAST Siemens VISTA Nanosphere hs-ctni Singulex hs-ctni Ortho Vitros ECi ES Tosoh AIA II Other, specify: Medical History (MHX) Page 7 of 10

8 c. Troponin at initial hospital presentation:... ng/ml d. Troponin during hospitalization:... ng/ml (peak - prior to PCI or CABG if done) INITIAL IS DEFINED AS THE FIRST VALUE RECORDED DURING THE INDEX ACS HOSPITALIZATION 44. Initial creatinine... mg/dl 45. Initial total cholesterol:... mg/dl 46. Initial triglycerides:... mg/dl 47. Initial LDL:... mg/dl 48. Initial HDL:... mg/dl 49. Initial hemoglobin A1c:... % G. PROCEDURES DURING HOSPITALIZATION FOR INDEX ACS EVENT 50. Stress test?... No Yes If Yes, then answer the following: a. Date of test: / / b. Stress test type... Exercise Pharmacological If Exercise, to target heart rate?... No Yes c. Imaging type:... EKG only Nuclear PET Echocardiogram d. Ischemia Result... Positive Negative Equivocal e. Fixed defect indicating an old MI... Present Absent f. Other findings (e.g, hypotension, delayed hysteresis): Medical History (MHX) Page 8 of 10

9 51. LV function assessed during hospitalization? No Yes If Yes, then answer the following: a. Initial LVEF: % or check one Normal/Low normal Mildly reduced Mild-moderately reduced Moderately reduced Moderate-severely reduced Severely Reduced b. Mitral regurgitation noted?... No Yes c. EF method: (check one) Echocardiography (by ultrasound) Contract ventriculography (by cath/angiogram) Radionuclide ventriculography or SPECT on stress testing (nuclear) 52. Diagnostic cardiac catheterization? No Yes If Yes, then answer the following: a. Date: / / b. Maximum stenosis (%): LAD LCx RCx LM 53. PCI performed?... No Yes If Yes, then answer the following: a. Date: / / b. Stents placed: c. Stent type:... Bare metal Drug-eluting d. Complications of PCI?... No Yes If Yes, type (check all that apply): Bleeding Vascular complication Cardiac tamponade Arrhythmia Stroke Contrast reaction Acute renal failure Medical History (MHX) Page 9 of 10

10 54. Coronary Artery Bypass Surgery performed? No Yes a. Date: / / H. CURRENT MEDICATIONS No Yes Unknown Name Daily Dose Units 55. ACE inhibitors Angiotensin II receptor blockers. 57. Aspirin Clopidogrel Other antiplatelet agents Anticoagulants (e.g., Warfarin) Beta-blockers Calcium channel blockers Digitalis/Digoxin Other inotropic agent (not digitalis) 65. Diuretics Statin lipid-lowering agents Non-statin lipid-lowering agents. 68. Nitrates Vasodilators (not ACE inhibitors) PO hypoglycemic antidiabetic Insulin Antiarrhythmics Female hormone replacement therapy. 74. Thyroid replacement therapy Antipsychotics Other drug class Other drug class Other drug class Other drug class... Medical History (MHX) Page 10 of 10

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg

Troponin Assessment. Does it Carry Clinical Message? Stefan Blankenberg. University Heart Center Hamburg Biomarkers for Optimal Management of Heart Failure Troponin Assessment Does it Carry Clinical Message? Stefan Blankenberg University Heart Center Hamburg Congress of the European Society of Cardiology

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

More information

Use of Biomarkers for Detection of Acute Myocardial Infarction

Use of Biomarkers for Detection of Acute Myocardial Infarction Use of Biomarkers for Detection of Acute Myocardial Infarction Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine

More information

Acute Coronary Syndrome

Acute Coronary Syndrome ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

More information

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS:

PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: 1 NAME: DATE OF BIRTH PLEASE LET US KNOW YOUR REASON FOR TODAY S VISIT : CURRENT MEDICATIONS (WITH DOSAGE) PLEASE INCLUDE VITAMINS AND HERBAL MEDICATIONS: PAST MEDICAL HISTORY (YOUR MEDICAL HISTORY) :

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention

Cardiology. Self Learning Package. Module 5: Pharmacology: Treatment of Acute Coronary. Prevention Cardiology Self Learning Package Module 5: Pharmacology: Treatment of Acute Coronary Syndromes, Module 5: Pharmacology: Hyperlipidaemia, Treatment of Acute Coronary Hypertension, Symdrome, Hyperlipidaemia,

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation

More information

For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy. This form must be scanned into the medical record. Do not remove from clinic.

For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy. This form must be scanned into the medical record. Do not remove from clinic. For Office Use Only: MA complete Date of Visit / / mm/dd/yyyy This form must be scanned into the medical record. Do not remove from clinic. UWMC Women s Health Care Center & SCCA Women s Cancer Center

More information

Course: Exercise and Aging for Special Populations

Course: Exercise and Aging for Special Populations Copyright EFS Inc. All Rights Reserved. Course: Exercise and Aging for Special Populations Session 2: Cardiovascular and Metabolic Disease Considerations for Exercise Program Design Presentation Created

More information

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE. Cranial Health History Form WASHINGTON UNIVERSITY SCHOOL OF MEDICINE Cranial Health History Form Welcome to the Neurosurgery Department at Washington University. To help us treat you, please fill this form out completely. Your Name:

More information

The Clinical Laboratory Working with Physicians to Improve Patient Care

The Clinical Laboratory Working with Physicians to Improve Patient Care The Clinical Laboratory Working with Physicians to Improve Patient Care Michael A. Pesce, PhD Professor Emeritus Columbia University Medical Center Department of Pathology and Cell Biology Objectives Troponin

More information

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr..

was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr.. Patient: was admitted to the Cardiology Service at the from Y /M /D to Y / M / D under the care of Dr.. Discharge Diagnoses include: q CAD-CCS Class: m 0 m 1 m 2 m 3 m 4 q Unstable angina q Non STEMI (non-st

More information

DO NOT SUBMIT OR FAX THIS PAGE TO COR F M L DD MM YY

DO NOT SUBMIT OR FAX THIS PAGE TO COR F M L DD MM YY DO NOT SUBMIT OR FAX THIS PAGE TO COR Patient # Patient Initials of Birth Medical Record Number F M L DD MM YY Patient Name Address Telephone (home) Telephone (work) Expected 6-month Follow-up Family Physician

More information

4. Which survey program does your facility use to get your program designated by the state?

4. Which survey program does your facility use to get your program designated by the state? STEMI SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and STEMI

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

Troponin when is an assay high sensitive?

Troponin when is an assay high sensitive? Troponin when is an assay high sensitive? Professor P. O. Collinson MA MB BChir FRCPath FRCP edin MD FACB EurClin Chem Consultant Chemical Pathologist and Professor of Cardiovascular Biomarkers, Departments

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better

10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better 10 Ways to Make the Use of High Sensitivity Cardiac Troponin Values Easier and Better Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department

More information

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018 Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

More information

DICOM Correction Item

DICOM Correction Item Correction Number CP-759 DICOM Correction Item Log Summary: Type of Modification Modification Rationale for Correction Name of Standard PS 3.16 The templates for Cardiovascular Patient History, originally

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

SUPPLEMENTAL MATERIAL. Supplemental digital content 1, Appendix 1. Ischemic symptoms and electrocardiography

SUPPLEMENTAL MATERIAL. Supplemental digital content 1, Appendix 1. Ischemic symptoms and electrocardiography SUPPLEMENTAL MATERIAL Supplemental digital content 1, Appendix 1. Ischemic symptoms and electrocardiography findings 1. Ischemic symptoms included any of the following: chest discomfort, arm discomfort,

More information

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011 Surgery and device intervention for the elderly with heart failure: assessing the need Devices and Technology for heart failure in 2011 Assessing cardiovascular function / prognosis (in the elderly): composite

More information

Table. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer.

Table. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer. Table. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer. Commercially available assays - Company/ platform(s)/ assay LoB a LoD b 99 th

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

UTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST

UTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST Please check the requested variables:, and/or. Obtained at Initial Hospital Recruitment Demographics: Age Gender Marital Status Ethnicity Race Height (inches) Weight (pounds) Main language spoken Socioeconomic

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute coronary syndrome(s), anticoagulant therapy in, 706, 707 antiplatelet therapy in, 702 ß-blockers in, 703 cardiac biomarkers in,

More information

Cardiovascular Diseases and Diabetes

Cardiovascular Diseases and Diabetes Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular

More information

2018 HPN Provider Summary Guide. Adult Cardiology Patients (18 Years and Older) Referral Guidelines

2018 HPN Provider Summary Guide. Adult Cardiology Patients (18 Years and Older) Referral Guidelines 12.2 CARDIOLOGY REFERRAL GUIDELINES Contracted Group: Southwest Medical Associates For Appointments: 888 S. Rancho Las Vegas, NV 89109 Phone: (702) 877-8654 Fax: (702) 242-7998 Adult Cardiology Patients

More information

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI) Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension

More information

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and 1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

The University of Texas Fitness Institute of Texas Health and Fitness Screening Questionnaire. Name Date Sex Date of Birth Address Phone UTEID

The University of Texas Fitness Institute of Texas Health and Fitness Screening Questionnaire. Name Date Sex Date of Birth Address Phone  UTEID The University of Texas Fitness Institute of Texas Health and Fitness Screening Questionnaire Name Date Sex Date of Birth Address Phone Email UTEID Please answer the following questions to the best of

More information

Outline Pretransplant Essential data Why comorbidities are important? For patients with cancer For patients given allogeneic HCT

Outline Pretransplant Essential data Why comorbidities are important? For patients with cancer For patients given allogeneic HCT Comorbidities before Allogeneic Hematopoietic Cell Transplantation (HCT) The HCT-specific Comorbidity Index (HCT-CI) Mohamed Sorror, M.D., M.Sc. FHCRC Seattle, WA Outline Pretransplant Essential data Why

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)

New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only

More information

Patient Name Date of Birth Age. Other phone ( ) . Other

Patient Name Date of Birth Age. Other phone ( )  . Other GASTROINTESTINAL & MINIMALLY INVASIVE SURGERY HEALTH HISTORY QUESTIONNAIRE Date Patient Name _ Date of Birth Age Daytime phone ( ) Other phone ( ) Email How did you hear about us? My doctor Yellow pages

More information

Contra-indications, Risks, and Safety Precautions for Stress Testing. ACSM guidelines, pg 20 7 ACSM RISK FACTORS. Risk Classifications pg 27

Contra-indications, Risks, and Safety Precautions for Stress Testing. ACSM guidelines, pg 20 7 ACSM RISK FACTORS. Risk Classifications pg 27 Contra-indications, Risks, and Safety Precautions for Stress Testing Data to Support Stress Testing How safe is stress testing? Contra-indications Termination Criteria Ellstad Chapt 5 ACSM Chapts 3-6 Seattle

More information

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

Cardiovascular Concerns in Intermediate Care

Cardiovascular Concerns in Intermediate Care Cardiovascular Concerns in Intermediate Care GINA ST. JEAN RN, MSN, CCRN-CSC CLINICAL NURSE EDUCATOR HEART AND & CRITICAL AND INTERMEDIATE CARE Objectives: Identify how to do a thorough assessment of the

More information

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study

Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

Treatment Strategies For Patients with Peripheral Artery Disease

Treatment Strategies For Patients with Peripheral Artery Disease Treatment Strategies For Patients with Peripheral Artery Disease Presented by Schuyler Jones, MD Duke University Medical Center & Duke Clinical Research Institute AHRQ Comparative Effectiveness Review

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet

More information

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding

More information

D M Y Y Y Y D D M M Y Y Y Y. Previous MI (apart from acute PCI) 0=no 1=yes 9=unknown

D M Y Y Y Y D D M M Y Y Y Y. Previous MI (apart from acute PCI) 0=no 1=yes 9=unknown I Patient details and Preoperative Data Date of Informed Consent dd-mm-yyyy (Please leave blank if waived by Ethics Committee) Please enter Patient ID in this format xxx-xx-xxx 3 digit code for the country,

More information

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition

More information

Ischemic Heart Disease

Ischemic Heart Disease Ischemic Heart Disease Definition: Ischemic heart disease (IHD) is a condition in which there is an inadequate supply of blood and oxygen to a portion of the myocardium; it typically occurs when there

More information

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012

Fifty shades of Troponin. Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012 Fifty shades of Troponin Dr Liam Penny The Queens Hotel, Cheltenham 4 th October 2012 Plaque-fissure and intracoronary thrombus Courtesy Prof. MJ Davies Acute Coronary Syndromes Plaque-fissure and intracoronary

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

Consensus Core Set: Cardiovascular Measures Version 1.0

Consensus Core Set: Cardiovascular Measures Version 1.0 Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized

More information

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS PREVENTING HOSPITAL READMISSIONS IN CARDIOVASCULAR PATIENTS Christina Cortez Perry, MSN, FNP-C, CCCC Cardiology Coordinator- Corpus Christi Medical Center 1 2 LEARNING OBJECTIVES Identify the target patient

More information

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri

Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.

More information

Pre Hospital and Initial Management of Acute Coronary Syndrome

Pre Hospital and Initial Management of Acute Coronary Syndrome Pre Hospital and Initial Management of Acute Coronary Syndrome Dr. Muhammad Fadil, SpJP 3rd SymCARD 2013 Classification of ACS ESC Guidelines for the management of Acute Coronary Syndrome in patients without

More information

Summary of Research and Writing Activities In Cardiovascular Disease

Summary of Research and Writing Activities In Cardiovascular Disease Summary of Research and Writing Activities In Cardiovascular Disease Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts

More information

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia Disorder of the Breast Approach to the Patient with Chest Pain Anthony J. Minisi, MD Department of Internal Medicine, Division of Cardiology Virginia Commonwealth University School of Medicine William

More information

MYOCARDIALINFARCTION. By: Kendra Fischer

MYOCARDIALINFARCTION. By: Kendra Fischer MYOCARDIALINFARCTION By: Kendra Fischer Outline Definition Epidemiology Clinical Aspects Treatment Effects of Exercise Exercise Testing Exercise Rx Summary and Conclusions References Break it down MYOCARDIAL

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Practice-Level Executive Summary Report

Practice-Level Executive Summary Report PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular

More information

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with

More information

Results of Ischemic Heart Disease

Results of Ischemic Heart Disease Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

Patient Information Last Name: First Name: Middle Initial: Address: City: State: Zip Code:

Patient Information Last Name: First Name: Middle Initial: Address: City: State: Zip Code: Patient Information Last Name: First Name: Middle Initial: Address: City: State: Zip Code: Date of Birth (MM/DD/YY): Social Security #: Sex: Male Female Home Phone #: Mobile Phone #: Email Address: Marital

More information

Heart Disease. Signs and Symptoms

Heart Disease. Signs and Symptoms Heart Disease The term "heart disease" refers to several types of heart conditions. The most common type is coronary artery disease, which can cause heart attack, angina, heart failure, and arrhythmias.

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

2016 General Practice/Family Practice Preferred Specialty Measure Set

2016 General Practice/Family Practice Preferred Specialty Measure Set 1 0059 5 0081 41 N/A 50 N/A 65 0069, EHR 66 0002, EHR Effective Clinical Care Effective Clinical Care Effective Clinical Care Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients

More information

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary Artery Disease: Revascularization (Teacher s Guide) Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention

More information

GWTG Post-Discharge Follow-up Form

GWTG Post-Discharge Follow-up Form Bold font = Required field Patient ID: Date of Hospital Admission: / / mm / dd / yyyy Date Follow-up Completed: / / mm / dd / yyyy PATIENT LOGISTICS Method used for Patient follow-up: Chart Review Health

More information

Angina Luis Tulloch, MD 03/27/2012

Angina Luis Tulloch, MD 03/27/2012 Angina Luis Tulloch, MD 03/27/2012 Acute coronary syndromes ACS STE > 1 mm, new LBBB* Increased cardiac enzymes STEMI Yes Yes NSTEMI No Yes UA No No *Recognize Wellen s sign/syndrome, posterior wall MI,

More information

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide is based on the 2017 KP National Coronary Artery Disease

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

CCRN Review Cardiovascular

CCRN Review Cardiovascular CCRN Review Cardiovascular Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Angina Definition discomfort that occurs when oxygen demand

More information

ARIC. HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION

ARIC. HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION ID NUMBER: FORM NAME: H F S DATE: 06/28/2012 VERSION: B Note: This form will only be done on a subset of participants.

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information